Harbour Investments, Inc. Vir Biotechnology, Inc. Transaction History

Harbour Investments, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 16, 2024	SELL	$7.76 - $10.29 $644 - $854	-83 Reduced 50.92%	80 $0
Q2 2022 Aug 15, 2022	SELL	$19.08 - $26.7 $286 - $400	-15 Reduced 8.43%	163 $4,000
Q4 2021 Feb 16, 2022	SELL	$30.97 - $54.03 $52,772 - $92,067	-1,704 Reduced 90.54%	178 $7,000
Q1 2021 Aug 17, 2021	BUY	$26.34 - $83.07 $49,545 - $156,254	1,881 Added 188100.0%	1,882 $96,000
Q1 2021 May 12, 2021	BUY	$26.34 - $83.07 $26 - $83	1 New	1 $0

228

88.4M

571K

216K

Ticker VIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 132,638,000
Market Cap $1.28B
Description
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...

Get notified when there are updates to the investment portfolio of Harbour Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Harbour Investments, Inc. with notifications on news.